UK Companies House feature
CYTOCELL LIMITED
Cash
£664K
-25.9% vs 2024
Net assets
£38M
+9.8% vs 2024
Employees
76
-1.3% vs 2024
Profit before tax
£4M
+36.1% vs 2024
Profile
- Company number
- 04231155
- Status
- Active
- Incorporation
- 2001-06-08
- Last accounts made up
- 2025-03-31
- Account category
- FULL
- Primary SIC
- 86900
- Hubs
- UK Healthcare
Net assets
7-year trend · vs UK Healthcare median
Accounts
7-year trend · latest 2025-03-31
| Metric | Trend | 2021-04-01 | 2022-03-31 | 2022-04-01 | 2023-03-31 | 2023-04-01 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|---|---|---|---|---|
| Turnover | — | £11,719,497 | — | £13,388,693 | — | £13,308,994 | £15,486,458 | |
| Operating profit | — | £3,935,508 | — | £4,457,660 | — | £2,923,463 | £3,846,360 | |
| Profit before tax | — | £3,649,449 | — | £4,146,356 | — | £2,640,698 | £3,594,416 | |
| Net profit | — | £3,160,706 | — | £3,509,447 | — | £2,776,524 | £3,430,207 | |
| Cash | — | £1,185,413 | — | £1,510,175 | — | £895,956 | £663,559 | |
| Total assets less current liabilities | — | £34,869,983 | — | £37,741,537 | — | £39,997,011 | £42,662,153 | |
| Net assets | — | £28,650,215 | — | £32,159,662 | — | £34,936,186 | £38,366,393 | |
| Equity | £25,489,509 | £28,650,215 | £28,650,215 | £32,159,662 | £32,159,662 | £34,936,186 | £38,366,393 | |
| Average employees | — | 65 | — | 72 | — | 77 | 76 | |
| Wages | — | £2,426,928 | — | £2,972,252 | — | £3,410,729 | £3,643,071 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- IFRS
- Reporting scope
- Standalone (parent only)
- Auditor
- James Cowper Kreston Audit
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Company has received a letter of support from the ultimate controlling party, Sysmex Corporation, to provide any necessary support to enable the Company to meet its liabilities as they fall due for a period of at least 12 months from the date on which the financial statements are approved.”
Significant events
- “There have been no significant events affecting the Company since the year end.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
4 active · 29 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| LENHARDT, Anthony John | Secretary | 2016-02-25 | — | — |
| IWAKABE, Kenji | Director | 2025-05-07 | Jun 1975 | Japanese |
| SMITH, Adrian Brian | Director | 2022-04-28 | Aug 1971 | British |
| WILLIAMS, Gregory Alun | Director | 2019-01-30 | Oct 1980 | British |
Show 29 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HAROLD, Theodora | Secretary | 2005-06-27 | 2012-07-19 |
| HEPBURN, Brian William | Secretary | 2001-06-08 | 2003-01-27 |
| TUCKER, Lee Francis | Secretary | 2003-04-25 | 2005-06-27 |
| BRIGHTON SECRETARY LIMITED | Corporate Nominee Secretary | 2001-06-08 | 2001-06-12 |
| ANSON, John George | Director | 2018-02-23 | 2022-03-31 |
| BUSHROD, Roger | Director | 2005-02-28 | 2006-12-14 |
| EVANS, Michael Robert, Dr | Director | 2014-02-28 | 2025-09-25 |
| HALL, Timothy Richard | Director | 2014-02-28 | 2018-10-19 |
| HAROLD, Theodora | Director | 2006-03-02 | 2008-12-11 |
| KENNEDY, Stewart Montgomery | Director | 2012-02-28 | 2016-02-29 |
| KUBOTA, Mamoru | Director | 2023-03-29 | 2024-03-28 |
| LAWRIE, Neil Martin, Dr | Director | 2005-02-25 | 2016-05-31 |
| MATSUO, Naohiko | Director | 2025-03-27 | 2026-03-31 |
| MORGAN, Sonia, Dr | Director | 2016-02-25 | 2017-06-21 |
| NAOTO, Kondo | Director | 2022-04-28 | 2025-03-27 |
| O'DONOVAN, Kevin | Director | 2006-12-14 | 2014-02-28 |
| ONO, Takashi | Director | 2024-05-16 | 2025-03-27 |
| OWEN, David Andrew Arlwydd, Dr | Director | 2016-02-25 | 2022-10-31 |
| OXLADE, David | Director | 2016-02-25 | 2026-04-30 |
| PAGE, Brian John, Dr | Director | 2006-12-14 | 2009-02-21 |
| PAGE, Brian John, Dr | Director | 2005-02-25 | 2006-12-13 |
| REDFERN, Jonathan | Director | 2006-12-14 | 2009-07-29 |
| REDFERN, Jonathan | Director | 2005-02-22 | 2005-12-16 |
| SOUTHERN, Edwin Mellor, Prof Sir | Director | 2016-02-25 | 2017-07-17 |
| TSUJIMOTO, Kenji | Director | 2017-10-18 | 2023-03-29 |
| BRIGHTON DIRECTOR LIMITED | Corporate Nominee Director | 2001-06-08 | 2001-06-12 |
| DART ENGINEERING (OVERSEAS) LTD | Corporate Director | 2006-03-02 | 2014-02-28 |
| DREADNOUGHT LTD | Corporate Director | 2008-12-12 | 2012-07-19 |
| LABTECH INTERNATIONAL LIMITED | Corporate Director | 2001-06-08 | 2005-02-24 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Oxford Gene Technology Ip Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 157 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-04-30 | TM01 | officers | termination director company with name termination date |
| 2026-04-30 | TM01 | officers | termination director company with name termination date |
| 2025-12-02 | AA | accounts | accounts with accounts type full |
| 2025-09-29 | TM01 | officers | termination director company with name termination date |
| 2025-06-04 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-05-08 | AP01 | officers | appoint person director company with name date |
| 2025-04-09 | AP01 | officers | appoint person director company with name date |
| 2025-04-08 | TM01 | officers | termination director company with name termination date |
| 2025-04-08 | TM01 | officers | termination director company with name termination date |
| 2024-12-20 | AA | accounts | accounts with accounts type full |
| 2024-06-17 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-05-17 | AP01 | officers | appoint person director company with name date |
| 2024-04-04 | TM01 | officers | termination director company with name termination date |
| 2023-12-21 | AA | accounts | accounts with accounts type full |
| 2023-06-09 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-04-03 | AP01 | officers | appoint person director company with name date |
| 2023-03-30 | TM01 | officers | termination director company with name termination date |
| 2023-03-24 | AA | accounts | accounts with accounts type full |
| 2022-11-01 | TM01 | officers | termination director company with name termination date |
| 2022-06-13 | CS01 | confirmation-statement | confirmation statement with no updates |
Credit score
Altman Z″ (private-firm) · reference 2025-03-31
5.00
SAFE
Altman Z″
- Working capital / Total assets 0.522 × 6.56 = +3.43
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets 0.054 × 6.72 = +0.36
- Book equity / Total liabilities 1.156 × 1.05 = +1.21
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory